Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines

Colaboración

Año: 2022

Garcia-Molina, P; Sola-Leyva, A; Luque-Navarro, PM; Laso, A; Rios-Marco, P; Rios, A; Lanari, D; Torretta, A; Parisini, E; Lopez-Cara, LC; Marco, C; Carrasco-Jimenez, MP

Título: PHARMACEUTICS

• Q1